Rx Communications Group

What types of companies do you work with?

We work with private and publicly traded life sciences and healthcare companies at all development stages, from early-stage biotechs building their first institutional profile to commercial-stage companies managing ongoing investor communications and analyst relationships.

What differentiates strong investor relations from weak execution?

Strong IR creates alignment between a company's fundamentals and how the market perceives it. Weak execution often leads to disconnects, where clinical progress or financial performance is not fully reflected in valuation because of unclear or inconsistent communication.

How do you tailor strategies for different stages of growth?

Approaches vary based on whether a company is private, pre-IPO, or publicly traded. Early-stage companies may focus on narrative development and visibility, while public companies often require ongoing engagement, perception management, and alignment with market expectations.